Reply: The repeat variant in MSH3 is not a genetic modifier for spinocerebellar ataxia type 3 and Friedreich's ataxia

Affiliations

¹ Department of Neurodegenerative Disease and Dementia Research Institute, UCL, UK.
² Institute of Molecular, Cell and Systems Biology, University of Glasgow, UK.
³ MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK.

Free article

Comment

Michael Flower et al. Brain. 2020.

Free article

. 2020 Apr 1;143(4):e26.

doi: 10.1093/brain/awaa044.

¹ Department of Neurodegenerative Disease and Dementia Research Institute, UCL, UK.
² Institute of Molecular, Cell and Systems Biology, University of Glasgow, UK.
³ MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK.

No abstract available

Comment on

MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1.
Flower M, Lomeikaite V, Ciosi M, Cumming S, Morales F, Lo K, Hensman Moss D, Jones L, Holmans P; TRACK-HD Investigators; OPTIMISTIC Consortium; Monckton DG, Tabrizi SJ. Flower M, et al. Brain. 2019 Jun 19;142(7):1876-86. doi: 10.1093/brain/awz115. Online ahead of print. Brain. 2019. PMID: 31216018 Free PMC article.
The repeat variant in MSH3 is not a genetic modifier for spinocerebellar ataxia type 3 and Friedreich's ataxia.
Yau WY, Raposo M, Bettencourt C, Labrum R, Vasconcelos J, Parkinson MH, Giunti P, Wood NW, Lima M, Houlden H. Yau WY, et al. Brain. 2020 Apr 1;143(4):e25. doi: 10.1093/brain/awaa043. Brain. 2020. PMID: 32154839 Free PMC article. No abstract available.